Screening Gene-Edited Cell Products for Mitochondrial Genome Alterations Through Deep Sequencing

Speciality: Gene & Cell Therapy


Speaker:

Amanjot Singh | HCP

Description:

Welcome to today’s episode, where we discuss the importance of screening gene-edited cell products for mitochondrial genome alterations using deep sequencing. Gene editing technologies like CRISPR have revolutionized modern medicine, but precise quality control remains critical. Deep sequencing allows researchers to detect even subtle changes in the mitochondrial DNA that may arise during the editing process. Identifying these alterations is essential, as mitochondrial mutations can affect cell function and safety, especially in therapeutic applications. By employing high-throughput sequencing, scientists ensure that gene-edited cells remain both effective and safe for clinical use. Stay tuned for more insights into the evolving world of cell therapy and genomic technologies.

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot